Gnubiotics Sciences SA

Biosimilar oligosaccharides to restore microbiome diversity

Swiss Startup - Gnubiotics Sciences Main Image

Gnubiotics Sciences SA is revolutionizing the microbiome health of humans and animals with a new category of complex molecules: glycans. Gnubiotics' unique and proprietary technology platform combines the power of chemistry and genomics to develop glycans that are proving to have unparalleled efficacy in restoring microbiome equilibrium, enabling the host to harness its power.

Only registered users have access to funding information.
Please log in or register to continue. Registration is free.

08.05.2023

Gnubiotics attracts nobel prize winner as advisor ahead of clinical trials (startupticker.ch)

21.04.2023

Gnubiotics wins first commercial customer for AMOBIOME (startupticker.ch)

10.05.2022

Companies worldwide look to Switzerland for tech solutions (startupticker.ch)

20.09.2021

Startups welcome executives aboard (startupticker.ch)

14.07.2021

The first cohort for the Venture Leaders Biotech roadshow revealed (startupticker.ch)

30.07.2020

Gnubiotics Sciences bags CHF 2.6 million (startupticker.ch)

17.06.2020

Die Finalisten des Swiss Economic Award stehen fest (startupticker.ch)

20.11.2019

GNUbiotics scales up production with renowned partner (startupticker.ch)

12.04.2019

With its first product Gnubiotics aims to improve pets? gut health (startupticker.ch)

28.12.2017

Gnubiotics Sciences raises CHF 2.3 million (startupticker.ch)

27.11.2017

First companies selected for StartLab incubator (startupticker.ch)

Last Tweets

Tweets by TwitterDev

02.04.2020

Gnubiotics accelerates testing of multivalent-glycan based pipeline candidates against viral entry of COVID-19

20.11.2019

GNUbiotics announces agreement with Evonik Nutrition

11.12.2018

GNUBiotics won the Ingredients category in the Startup Innovation Challenge at HiE 2018 in Frankfurt.

11.05.2018

GNUBiotics Sciences introduces next generation HMOs composed of up to 130 diverse microbiota accessible carbohydrates (MACs) structures

29.05.2017

Gnubiotics wins Venture Kick on stage two

09.02.2017

Gnubiotics wins Venture Kick on stage one

No Jobs

Videos

Discover microbiota modulation via natural mechanism of action

https://www.youtube.com/watch?v=SsN4L9hW_Os

Documents

GNUbiotics Executive Summary

TOP 100 Swiss Startup Award

The TOP 100 Swiss Startup Ranking features the 100 most promising startups that are not older than five years and are selected by a jury of early-stage investors.

TOP 100 Swiss Startups 2018 TOP 100 Swiss Startups 2017

Website

Venture Kick

Venture Kick supports potential entrepreneurs with start capital up to CHF 150'000 as well as hands-on execution support and access to a nationwide network of investors and experts in the startup field. Multiple times per year, 8 selected projects get the opportunity to present their business ideas in front of a panel. The 5 most promising projects enter the support process. After 9 months at the latest, the startups incorporate and enter the market. Since 2007, Venture Kick has invested over CHF 58 million in over 1111 projects.

Venture Kick (30'000) 2017

Website